General Information of DTT (ID: TT6A17J)

DTT Name Ataxin-3 messenger RNA (ATXN3 mRNA) DTT Info
Gene Name ATXN3

Molecule-Related Drug & Molecule List

Molecule-Related Drug List
Molecule Type:
DTT
DTP
DME
Drug Status:
Clinical Trial Drug(s)
2 Clinical Trial Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
BIIB132 DMUJ0EL Spinocerebellar ataxia type 3 8A03.16 Phase 1 [1]
ION260 DMR2RFL Spinocerebellar ataxia type 3 8A03.16 Phase 1 [2]
------------------------------------------------------------------------------------
Molecule Interaction Atlas

References

1 ClinicalTrials.gov (NCT05160558) A Phase 1, Blinded, Randomized, Placebo-controlled Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of BIIB132 Administered Intrathecally to Adults With Spinocerebellar Ataxia 3. U.S.National Institutes of Health.
2 Clinical pipeline report, company report or official report of Ionis